Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report

Overview of attention for article published in Infection and Drug Resistance, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,202 followers.

Llamado a todos los angeles arcanos de la salud llamado a todos los angeles arcanos de la salud SOS SOS SOS SOS 🆘🆘🆘🆘 Para frenar definitivamente todas las variantes del COVID 19 sin ningún obstáculo 😇🙏🙏😇😇🙏🙏😇😇🙏🙏😇😇😇😇

10 Jan 2024

Reply Repost Favourite

China has 17 of the world's 320 pro-Actemra COVID-19 studies and 9 of the world's 60 pro-Actemra COVID-19 meta-analyses (ChunChen, WeijunJiang, LimeiKang, ZhenluLi, LiliLuo, QiuWei, JingZhang, JieZhao, MengZhao) Chunlan Fu (5t, 0c) has become China's 18th: